Development and Validation of a Simoa Assay for Determination of Recombinant Batroxobin in Human Serum
…concentrations to evaluate pharmacokinetic parameters for phase I clinical studies. Therefore, a sensitive method is urgently needed to support the clinical pharmacokinetic evaluation of S3101. In this study, a sensitive…
read more